Patients to receive innovative treatments in new state-of-the-art cancer centre

Cancer patients will benefit from a £20 million investment that will see a new state-of-the-art diagnostic and treatment centre built in Surrey.

Royal Surrey NHS Foundation Trust is working with specialist oncology group GenesisCare to provide the new facility, which is expected to open in late 2021.

Eligible NHS patients and staff will have access to state-of-the-art technology as a result of this partnership, including a new Magnetic Resonance Linear Accelerator (MR Linac).

The MR Linac works by delivering highly precise radiation to tumours whilst imaging in real time and it is hoped that it will advance treatments for patients with prostate, pancreatic, lung and liver cancers. Royal Surrey will be the third NHS trust nationally to offer this treatment to NHS patients.

Royal Surrey will continue to deliver world leading treatments and high quality care to NHS cancer patients across the South East of England. In addition to working with NHS patients and staff, GenesisCare will also provide private patient radiotherapy services.

Dr Robert Laing, Consultant Clinical Oncologist at Royal Surrey, said: “This is an important step forward that will allow us to treat even more patients and offer the very latest in radiotherapy.

“I am looking forward to offering new training programmes to build our hospital’s expertise in these new technologies to a wider number of clinicians.

“Gaining access and experience to the latest leading technologies and equipment that are currently limited in their availability in the UK puts innovation where it matters most – focused on treating more patients more effectively.”

Joe Mills, Director of Strategy at Royal Surrey, said: “Royal Surrey is proud to be a tertiary cancer centre serving a population of two million patients across the South East of England and our work will continue to evolve within our collaboration with GenesisCare.

“This partnership will set new standards for how the NHS and private care initiatives can and will support innovation to improve health services for patients.

“We are particularly excited about the chance to not only offer treatment advances, but also to demonstrate how this has the potential to make positive strides forward in quality of life for our patients.”

James McArthur, UK General Manager, GenesisCare, said: “This new partnership is focused on expanding access to world-class care for people with cancer in the South East of England.

“Working closely with Royal Surrey, we will introduce innovative new therapies, treatment techniques and research, with a mission to improve life outcomes for cancer patients.”

Related articles

Honouring Clinical Excellence & Leadership: GenesisCare Launches Inaugural Global Physician Recognition Program

GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees

SABR Consortium Annual Professional Conference 2021

Annual research report 2020